• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    17.64 Up 0.09(0.51%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:17.55
    Open:17.54
    Bid:17.64 x 400
    Ask:17.65 x 1600
    1y Target Est:28.13
    Beta:3.66884
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:17.26 - 17.67
    52wk Range:9.20 - 20.63
    Volume:260,580
    Avg Vol (3m):381,940
    Market Cap:616.78M
    P/E (ttm):N/A
    EPS (ttm):-1.13
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PETXUp 0.51%616.78M
    ZTSDown 0.17%22.84B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):906.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.37
    Quarterly EPS Est (Sep-15) :-0.38
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.85

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback